Status | Study |
Recruiting |
Study Name: TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection Condition: Intrahepatic Cholangiocarcinoma Date: 2015-10-27 Interventions: Procedure: TACE+Tegafur Tegafu |
Recruiting |
Study Name: Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2015-08-10 Interventions: Procedure: conventional lymph node dissection |
Recruiting |
Study Name: Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-08-07 Interventions: Drug: oxaliplatin and gemcitabine |
Recruiting |
Study Name: 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2015-07-29 Interventions: Device: SIR-Spheres microspheres (Yttrium-90 Microspheres) |
Active, not recruiting |
Study Name: Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-04-23 Interventions: Drug: Dasatinib Other Name: SPRYCEL ™ |
Not yet recruiting |
Study Name: Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma Condition: Hepatocellular Carcinoma Intrahepatic Cholangiocarcinoma Date: 2015-04-08 Interventions: Device: Delcath Hepatic Delivery System |
Terminated |
Study Name: Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2014-09-30 Interventions: Drug: Gemcitabine Other Name: |
Terminated |
Study Name: A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma Condition: Unresectable Intrahepatic Cholangiocarcinoma Resectable Date: 2014-09-25 Interventions: Drug: Gemcitabine Other Name: |
Active, not recruiting |
Study Name: Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery Condition: Stage III Intrahepatic Cholangiocarcinoma Stage IVA Date: 2014-07-08 Interventions: Drug: Cisplatin Given IV |
Recruiting |
Study Name: Next Generation Sequencing in Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2014-07-03 Interventions: Other: exposure to different risk factors and molecular assessment |